Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Madison R. Mack is active.

Publication


Featured researches published by Madison R. Mack.


Nature Communications | 2017

Sensory TRP channels contribute differentially to skin inflammation and persistent itch

Jing Feng; Pu Yang; Madison R. Mack; Dariia Dryn; Jialie Luo; Xuan Gong; Shenbin Liu; Landon K. Oetjen; Alexander Zholos; Zhinan Mei; Shijin Yin; Brian S. Kim; Hongzhen Hu

Although both persistent itch and inflammation are commonly associated with allergic contact dermatitis (ACD), it is not known if they are mediated by shared or distinct signaling pathways. Here we show that both TRPA1 and TRPV1 channels are required for generating spontaneous scratching in a mouse model of ACD induced by squaric acid dibutylester (SADBE), a small molecule hapten, through directly promoting the excitability of pruriceptors. TRPV1 but not TRPA1 channels protect the skin inflammation, as genetic ablation of TRPV1 function or pharmacological ablation of TRPV1-positive sensory nerves promotes cutaneous inflammation in the SADBE-induced ACD. Our results demonstrate that persistent itch and inflammation are mediated by distinct cellular and molecular mechanisms in a mouse model of ACD. Identification of distinct roles of TRPA1 and TRPV1 in regulating itch and inflammation may provide new insights into the pathophysiology and treatment of chronic itch and inflammation in ACD patients.Allergic contact dermatitis is associated both with persistent itch and inflammation, but it is not known if these are mediated by shared signaling pathways. The authors show that persistent itch requires both TRPA1 and TRPV1, while TRPV1 has a protective role against skin inflammation in mice.


bioRxiv | 2017

Macrophage-to-sensory neuron crosstalk mediated by Angiotensin II type-2 receptor elicits neuropathic pain

Andrew J. Shepherd; Aaron D. Mickle; Bryan A. Copits; Páll Karlsson; Suraj Kadunganattil; Judith P. Golden; Satya M Tadinada; Madison R. Mack; Simon Haroutounian; Annette D. de Kloet; Vijay K. Samineni; Manouela V. Valtcheva; Lisa A. McIlvried; T. Sheahan; Sanjay Jain; Pradipta Ray; Yuriy M. Usachev; Gregory Dussor; Brian S. Kim; Eric G. Krause; Theodore J. Price; Robert W. Gereau; Durga P. Mohapatra

Peripheral nerve damage initiates a complex series of cellular and structural processes that culminate in chronic neuropathic pain. Our study defines local angiotensin signaling via activation of the Angiotensin II (Ang II) type-2 receptor (AT2R) on macrophages as the critical trigger of neuropathic pain. An AT2R-selective antagonist attenuates neuropathic, but not inflammatory pain hypersensitivity in mice, and requires the cell damage-sensing ion channel transient receptor potential family-A member-1 (TRPA1). Mechanical and cold pain hypersensitivity that are characteristic of neuropathic conditions can be attenuated by chemogenetic depletion of peripheral macrophages and AT2R-null hematopoietic cell transplantation. Our findings show no AT2R expression in mouse or human sensory neurons, rather AT2R expression and activation in macrophages triggers production of reactive oxygen/nitrogen species, which trans-activate TRPA1 on sensory neurons. Our study defines the precise neuro-immune crosstalk underlying nociceptor sensitization at the site of nerve injury. This form of cell-to-cell signaling represents a critical peripheral mechanism for chronic neuropathic pain, and therefore identifies multiple analgesic targets.


Proceedings of the National Academy of Sciences of the United States of America | 2018

Macrophage angiotensin II type 2 receptor triggers neuropathic pain

Andrew J. Shepherd; Aaron D. Mickle; Judith P. Golden; Madison R. Mack; Carmen M. Halabi; Annette D. de Kloet; Vijay K. Samineni; Brian S. Kim; Eric G. Krause; Robert W. Gereau; Durga P. Mohapatra

Significance Neuropathic pain is a widespread problem that is undermanaged by currently available analgesic drugs. An antagonist of the type II angiotensin II receptor (AT2R) reduces pain behaviors related to neuropathy, suggesting that angiotensin receptor signaling is involved in this pain. We find that AT2R expression is detected not in sensory neurons themselves, but in macrophages that infiltrate the site of nerve injury. Inducible depletion of peripheral macrophages attenuates mechanical and cold pain hypersensitivity related to neuropathy, as does transplantation of AT2R-null bone marrow into an otherwise WT recipient. Our observations provide powerful evidence that neuropathic pain is dependent upon angiotensin signaling, macrophages, and the AT2R-mediated downstream signaling therein. Peripheral nerve damage initiates a complex series of structural and cellular processes that culminate in chronic neuropathic pain. The recent success of a type 2 angiotensin II (Ang II) receptor (AT2R) antagonist in a phase II clinical trial for the treatment of postherpetic neuralgia suggests angiotensin signaling is involved in neuropathic pain. However, transcriptome analysis indicates a lack of AT2R gene (Agtr2) expression in human and rodent sensory ganglia, raising questions regarding the tissue/cell target underlying the analgesic effect of AT2R antagonism. We show that selective antagonism of AT2R attenuates neuropathic but not inflammatory mechanical and cold pain hypersensitivity behaviors in mice. Agtr2-expressing macrophages (MΦs) constitute the predominant immune cells that infiltrate the site of nerve injury. Interestingly, neuropathic mechanical and cold pain hypersensitivity can be attenuated by chemogenetic depletion of peripheral MΦs and AT2R-null hematopoietic cell transplantation. Our study identifies AT2R on peripheral MΦs as a critical trigger for pain sensitization at the site of nerve injury, and therefore proposes a translatable peripheral mechanism underlying chronic neuropathic pain.


Immunity | 2016

Superficial Immunity: Antimicrobial Responses Are More Than Skin Deep

Madison R. Mack; Brian S. Kim

The skin barrier is essential for host defense, but how the skin provides protection when the barrier is breached is not well understood. In this issue of Immunity, Gallo and colleagues report that keratinocytes integrate signals from antimicrobial peptides via MAVS signaling to amplify their antiviral immune response.


Cell | 2017

Sensory neurons co-opt classical immune signaling pathways to mediate chronic itch

Landon K. Oetjen; Madison R. Mack; Jing Feng; T. Whelan; Haixia Niu; Changxiong J. Guo; Sisi Chen; Anna M. Trier; Amy Xu; Shivani V. Tripathi; Jialie Luo; Xiaofei Gao; Lihua Yang; Samantha L. Hamilton; Peter L. Wang; Jonathan R. Brestoff; Richard Brasington; Andras Schaffer; Frank Brombacher; Chyi-Song Hsieh; Robert W. Gereau; Mark J. Miller; Zhou-Feng Chen; Hongzhen Hu; Steve Davidson; Qin Liu; Brian S. Kim


The Journal of Allergy and Clinical Immunology | 2017

The antimicrobial peptide human beta-defensin 2 promotes itch through Toll-like receptor 4 signaling in mice

Jing Feng; Jialie Luo; Madison R. Mack; Pu Yang; Feng Zhang; Guan Wang; Xuan Gong; Tao Cai; Zhinan Mei; Brian S. Kim; Shijin Yin; Hongzhen Hu


Journal of Investigative Dermatology | 2017

580 Neuronal IL-4Rα and JAK1 signaling mediate chronic itch

Landon K. Oetjen; Madison R. Mack; T. Whelan; Changxiong J. Guo; Lihua Yang; Samantha L. Hamilton; Peter L. Wang; Haixia Niu; Jing Feng; Amy Xu; Shivani V. Tripathi; Jialie Luo; Jonathan R. Brestoff; A. Shaffer; Chyi-Song Hsieh; Robert W. Gereau; Mark J. Miller; Hongzhen Hu; S. Davidson; Qin Liu; Brian S. Kim


The Journal of Allergy and Clinical Immunology | 2018

Neuronal IL-4Rα and JAK1 signaling critically mediate atopic dermatitis-associated

Landon K. Oetjen; Madison R. Mack; Jing Feng; T. Whelan; Haixia Niu; Changxiong J. Guo; Sisi Chen; Anna M. Trier; Amy Xu; Shivani V. Tripathi; Jialie Luo; Xiaofei Gao; Lihua Yang; Samantha L. Hamilton; Peter L. Wang; Jonathan R. Brestoff; Richard Brasington; Andras Schaffer; Frank Brombacher; Chyi-Song Hsieh; Robert W. Gereau; Mark J. Miller; Zhou-Feng Chen; Hongzhen Hu; Steve Davidson; Qin Liu; Brian S. Kim


Journal of Investigative Dermatology | 2018

1017 Natural killer cell dysregulation underlies atopic dermatitis

Madison R. Mack; Jonathan R. Brestoff; Haixia Niu; T. Whelan; Landon K. Oetjen; N. Bodet; F. Wang; Amy Xu; E. Park; D. Margolis; W. Yokoyama; Brian S. Kim


Archive | 2017

The antimicrobial peptide hBD2 promotes itch through Toll-like receptor 4 signaling in mice.

Jing Feng; Jialie Luo; Madison R. Mack; Pu Yang; Feng Zhang; Guan Wang; Xuan Gong; Tao Cai; Zhinan Mei; Brian S. Kim; Shijin Yin; Hongzhen Hu

Collaboration


Dive into the Madison R. Mack's collaboration.

Top Co-Authors

Avatar

Brian S. Kim

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Hongzhen Hu

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Jialie Luo

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Jing Feng

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Amy Xu

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Landon K. Oetjen

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Robert W. Gereau

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

T. Whelan

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Haixia Niu

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Jonathan R. Brestoff

Washington University in St. Louis

View shared research outputs
Researchain Logo
Decentralizing Knowledge